Clinical Trial: A Trial of Ribupatide Injection in Participants With Obesity and Knee Osteoarthritis

U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07709910) titled 'A Trial of Ribupatide Injection in Participants With Obesity and Knee Osteoarthritis' on July 08.

Brief Summary: The study is being conducted to evaluate the efficacy and safety of Ribupatide Injection in participants with obesity and knee osteoarthritis, and to explore its improvement on knee joint structure.

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Participants With Obesity and Knee Osteoarthritis

Intervention: DRUG: Ribupatide Injection

Ribupatide Injection

DRUG: Placebo

Placebo

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.

Disclaimer: Curated by HT S...